During the past decade, Universitätsklinikum Frankfurt - Medizinische Klinik 1 conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" #1 sponsor was "Camurus AB" with 2 trials, followed by "Zealand Pharma" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "HepNet Study House, German Liverfoundation" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator and "Merck Serono GmbH, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" are "Acromegaly" (2 trials), "Short Bowel Syndrome" (2 trials), "Acute Hepatitis C" (1 trials), "Biliary Tract Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "CAM2029 (octreotide subcutaneous depot)" (2 trials), "Placebo" (2 trials), "glepaglutide" (2 trials), "Bintrafusp alfa" (1 trials) and "Golimumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Frankfurt - Medizinische Klinik 1" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Frankfurt - Medizinische Klinik 1". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitätsklinikum Frankfurt - Medizinische Klinik 1, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Frankfurt - Medizinische Klinik 1, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".